JR8603
/ JiaRay Group
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
September 10, 2025
A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=94 | Recruiting | Sponsor: JiaRay Group | N=65 ➔ 94
Enrollment change • Colorectal Cancer • Esophageal Cancer • Gastric Cancer • Oncology • Solid Tumor
August 22, 2025
A First-in-Human, Open-Label, Dose Escalation and Expansion Study of JR8603 in Patients with Advanced Solid Tumors
(ChiCTR)
- P1 | N=94 | Recruiting | Sponsor: Harbin Medical University Cancer Hospital; Harbin Medical University Cancer Hospital | -> Recruiting
Enrollment open • Solid Tumor
January 23, 2025
A First-in-Human Escalation and Expansion Study of Patients with Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=65 | Recruiting | Sponsor: JiaRay Group
New P1 trial • Colorectal Cancer • Esophageal Cancer • Gastric Cancer • Oncology • Solid Tumor
1 to 3
Of
3
Go to page
1